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Abstract
Objectives: To compare three methods for evaluating treatment adherence in a 7-day controlled treatment period for 
malaria in children in Rwanda.
Methods: Fifty-six children (< 5 years) with malaria were recruited at the University Hospital of Butare, Rwanda. Patients 
were treated with quinine sulfate, taste-masked, pellets during seven days: three days in hospital (in-patient) followed 
by a four-day out-patient period. Three methods to evaluate medication adherence among patients were compared: 
manual pill count of returned tablets, patient self-report and electronic pill-box monitoring. These pill-boxes were 
equipped with a microchip registering date and time of every opening. Medication adherence was defined as the 
proportion of prescribed doses taken. The inter-dose intervals were analysed as well.
Results: Medication adherence data were available for 54 of the 56 patients. Manual pill count and patient self-report 
yielded a medication adherence of 100% for the in- and out-patient treatment periods. Based on electronic pill-box 
monitoring, medication adherence during the seven-day treatment period was 90.5 ± 8.3%. Based on electronic pill-
box monitoring inpatient medication adherence (99.3 ± 2.7%) was markedly higher (p < 0.03) than out-patient 
adherence (82.7 ± 14.7%), showing a clear difference between health workers' and consumers' medication adherence.
Conclusion: Health workers' medication adherence was good. However, a significant lower medication adherence was 
observed for consumers' adherence in the outpatient setting. This was only detected by electronic pill-box monitoring. 
Therefore, this latter method is more accurate than the two other methods used in this study.
Background
Malaria is one of the world's most deadly diseases[1] with
approximately 881,000 deaths every year, and nine out of
ten deaths occurring in sub-Saharan Africa[1]. Addition-
ally, 85% of all malaria-related deaths are recorded in chil-
dren under five years of age.
The effective control and treatment of malaria presents
enormous challenges, especially in sub-Saharan Africa
where access to medicines and health care is limited, and
multiple cases of treatment failure have been reported[2].
Poor adherence to anti-malarial treatment, from both
health workers and consumers, may importantly contrib-
ute to treatment failure. Poor treatment adherence leads
to sub-therapeutic drug concentrations in the body,
which will not eradicate all parasites and allow growth of
resistant parasites. Drug concentrations in the body can
become subtherapeutic either by missed doses or by not
timely taken doses. Hence, when assessing antimalarial
treatment adherence it is also important to assess the
timing of dose intake.
However, the evaluation of medication adherence in
daily practice or in research remains challenging[3,4], in
particular in the developing settings where malaria is
pandemic[5,6]. Some studies have used quantitative
methods such as patient and clinician reports, but ques-
tions can be raised about the reliability of these meth-
ods[7,8]. Patient self-reports have the disadvantage that
they might be influenced by the desire of the patient to
comply, or his/her denial of the illness[4], whereas infor-
mation obtained through clinician reports could be
biased by the interest the clinician may have in the
patient's treatment[9,10]. Therefore, a more objective and
exact alternative is provided by electronic pill-box moni-
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toring of medication adherence. Bottle caps with built-in
microchips allow to record the date and time of every
opening of the medication bottle. This method has
proven its value in a variety of populations with medical
disorders[4,10-15], but only rarely in sub-Saharan
Africa[16].
The objective of this study was twofold. Firstly, to com-
pare three methods for evaluating adherence to an anti-
malarial treatment with quinine pellets during a 7-day
controlled treatment in Rwandan children. The three
methods of adherence assessment were manual pill
count, self-report and electronic pill-box monitoring.
Secondly, since the treatment consisted of an inpatient
and an outpatient period, health workers' adherence
(inpatient period) was compared to consumers' adher-
ence (outpatient period).
Methods
Study population
The study took place at the Rwandan University Hospital
of Butare ("Centre Hospitalier Universitaire de Butare")
from July to August 2006 and involved parents/guardians
of 56 children less than five years of age with mild diag-
nosed malaria treated with taste-masked quinine sulfate
pellets[17]. Among them 54 children provided exploit-
able data. The population sample complies with WHO
guidelines[18].
Study design
A seven day treatment regimen started with three days of
full hospitalization. The full treatment consisted of 21
doses with 10 doses in hospital and 11 in the outpatient
setting. Doses were calculated according to body weight.
In the hospital, the drug was given by trial nurses three
times daily at fixed time points: 6:00 am, 2:00 pm and
10:00 pm. In case of vomiting within half an hour after
dosing, the dose was repeated and the nurse was
instructed to notify this in the adverse event form. The
children were discharged on the fourth day, after blood
samples were taken for pharmacokinetic analysis
(reported elsewhere) [17]. Whilst the discharge day was
shared between the in- and outpatient setting, day five to
seven were fully spent in the outpatient setting.
Upon discharge, parents/guardians were given the
appropriate number of doses to complete the seven day
regimen and were instructed on dosing frequency and
time. This study was approved by the Ethics Committees
of both Ghent University and the Ministry of Health in
Rwanda.
Taste-masked quinine sulfate pellets were developed
and provided by Ghent University, faculty of pharmacy,
laboratory of pharmaceutical technology, and details
about this formulation were reported elsewhere[17].
Every dose was individually packed in capsules and all
doses per patient were delivered in labeled electronically
monitored pill-boxes. Each pill-box was equipped with a
microchip in its lid, registering the date and time of each
opening (Medication Event Monitoring System (MEMS®),
Aardex Corporation, Geneva, Switzerland). The parents/
guardians and nurses were not aware of this recording
system. However, they were instructed not to abuse the
opening/closing of the pill-boxes and to keep them out of
reach of children.
Medication adherence assessment
Medication adherence was assessed in three different
ways. The first method was manual pill count. For the
hospitalization period, 12 doses were put in a labeled pill-
box for every child by a physician and handed over to the
nurse in charge. At the end of the hospitalization period,
the physician counted again and noted down the exact
number of capsules remaining in the pillbox for every
child (this should be 2 or 3 (in 8 children) if the child did
not vomit). Consequently, the physician refilled each box
with 11 doses. The boxes were handed over to the parent/
guardian for the ambulatory treatment. In the outpatient
period, parents/guardians were asked to come to the hos-
pital for extra pills if needed. This could be necessary for
replacing vomited doses or other lost doses. All transport
fees were reimbursed in such case. At the end of treat-
ment, parents/guardians were asked to return the pill-
boxes and the number of capsules in every pill-box was
counted again.
A second method assessed medication adherence via
self-report of the nurses and parents/guardians. This was
done using a questionnaire filled out by the trial nurses at
the end of hospitalization and the treatment period,
respectively. Nurses and Parents/guardians were asked at
which time the children had taken their medication dur-
ing hospitalization and the three ambulatory days, and
how often they had opened the box. They were also asked
for the number of times they had opened the pill-boxes
and not taken medication, and the number of times they
had taken medication from other sources than the
received pill-boxes. This questionnaire was tested and
validated in a pilot study (involving four children for a 7-
days treatment) before the present study.
Electronic pill-box monitoring was used as a third way
of assessing medication adherence. Each opening was
considered as a single dose intake. After the seven days
treatment period, electronic pill-box monitoring data
were downloaded to a personal computer using dedicated
software (PowerView version 3.3.3 software - Aardex
Corp, Geneva, Switzerland).
Analysis of medication adherence
Since a standard definition and grades of good medica-
tion adherence for malaria treatment are lacking, medica-Twagirumukiza et al. Malaria Journal 2010, 9:206
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tion adherence was analyzed according to five different
definitions, which consider a patient as adherent to the
treatment when:
(A) at least 70% of all doses are taken
(B) at least 80% of all doses are taken
(C) At least 90% of all doses are taken
(D) at least 80% of all doses are taken within four 
hours around due time (delayed/advanced for two 
hours)
(E) at least 80% of all doses are taken within two hours 
around due time (delayed/advanced for one hour)
Definitions D and E were only used for the electronic
pill-box monitoring method, as the two other methods
did not reveal reliable data on the timing of the dose
intake. Medication adherence persistence in this study
was not addressed, because of the short treatment period.
Statistical analysis
The comparison between inpatient and outpatient data
were done by chi-squared proportions' comparison test.
The significance level was set at a p-value < 0.05. Data are
expressed as percentages, means and standard deviations
and/or 95% confidence intervals. Comparison of the 3
methods using Kappa statistics or correlation was not
possible because the manual pill count and self report
results were constant (adherence of 100%). For the same
reason, statistics related to the interdependence of suc-
cessive doses (or intervals between doses), were less
informative and are skipped in the manuscript.
Results
Comparison between the medication adherence 
assessment methods over the full 7-day treatment period
Medication adherence data from 54 of the 56 patients
(96.4%) were recovered after completion of the seven
days treatment. Two parents did not return their elec-
tronically monitored pill-box. Medication adherence
assessed by the three methods are shown in Table 1.
According to manual pill count, the medication adher-
ence was 100% (for definitions A to C). In fact, no parent
or guardian returned any capsule at the final visit. Also
for the self-report method, adherence was 100% for defi-
nitions A to C. All parents/guardians stated to have
exactly followed the given instructions, and they con-
firmed that they had been compliant with the time sched-
ule. Using the electronic pill-box monitoring, medication
adherence varied largely according to the used definition
(Table 1). None of the children got 100% medication
adherence. The strictest definition (E) yielded 33.3% of
adherence, whereas the least strict definition (A) yields an
adherence of 83.3% throughout the seven day treatment
regimen.
An overall view on the dosing times according to the
electronic pill-box monitoring records shows that the
morning intake ranged from 5:00 am to 8:00 am (mode =
6:00 am), the noon intake from 10:00 am to 5:00 pm
(mode = 2:00 pm) and the evening intake ranged from
7:00 pm to 3:00 am (mode = 10:00 pm) (Figure 1).
Four parents/guardians confirmed to have opened the
electronically monitored pill-box accidentally. Three
guardians reported that their child vomited and that the
dose was replaced within 30 minutes. However, this has
not been confirmed by electronic pillbox monitoring.
None of parents/guardians had taken medication from
other sources than the received pill-boxes, nor did any
parent/guardian return to the hospital for extra pills.
Health workers' versus consumers' adherence
Manual pill count and self-report did not show any differ-
ences between health workers' (inpatient) and consumers'
(outpatient) adherence, as adherence was 100% through-
out the treatment for these two methods. Electronic pill-
box monitoring however shows a much lower compliance
during the outpatient than during the inpatient period
(Table 1). When looking at the number of missed doses
rather than at medication adherence (Table 2), this differ-
ence is even more pronounced. In the hospital, only two
out of the 429 monitored doses (0.5%) were missed, ver-
sus 72 of the 568 (12.7%) monitored doses in the outpa-
tient setting (Table 3).
Additionally, electronic pill box monitoring allows to
assess the time of dosing throughout the treatment. The
two missed doses in the hospital were evening doses. In
the outpatient setting, 12% of the morning doses, 18% of
the noon doses and 9% of the evening doses were missed.
Table 3 lists the number of doses taken more than 1 or 2
hours too early or too late, which were significantly
higher in the outpatient than in the inpatient setting. As a
consequence, the same difference between inpatient and
outpatient setting was found for deviations in the inter-
dose interval (Table 4).
Discussion
In this study manual pill count, self-reports and elec-
tronic pill-box monitoring were used to assess the adher-
ence of health workers and parents/guardians of 56
children to a seven-day malaria treatment with taste-
masked quinine sulfate pellets. To the authors' knowl-
edge, this is the first study to compare these three meth-
ods of medication adherence assessment in a short-
period treatment in an African setting. In addition,
although medication adherence during hospitalization
a n d  i n  a n  a m b u l a t o r y  s e t t i n g  h a v e  b e e n  w i d e l y  d i s -
cussed[5,16,19-21], the authors are not aware of data
comparing hospital to the outpatient malaria medication
adherence in the same study elsewhere in sub-Saharan
settings. Hence, this study is the first to report on the dif-
ference between health workers' (inpatient) and consum-Twagirumukiza et al. Malaria Journal 2010, 9:206
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ers' (outpatient) medication adherence in the African
setting. The study also introduces the importance of
assessing the inter-dose intervals when studying anti-
malarial medication adherence.
Results from the pillbox monitoring revealed a clearly
lower adherence in the outpatient setting (consumers'
adherence) than in the inpatient setting (health workers'
adherence) (Table 1). The number of missed doses and
time of dose intake variability was higher during the out-
patient period (Tables 2 &3). In outpatients, the evening
doses were the most adhered, followed by the morning
doses. This finding, if confirmed by other studies, may
imply that once daily dosing treatments should better be
given in the evening than in the morning hours. The dif-
ference in medication adherence between the health
workers and the consumers is probably due to the hospi-
tal setting and the health workers' professional compe-
tence, but may also be influenced by the child's condition,
which was improved at hospital discharge.
The very similar medication adherence estimates
obtained from self-report and manual pill count, which
are markedly higher than the estimate obtained by elec-
tronic pill-box monitoring (Table 1) is in line with litera-
ture data, and has been attributed to the fact that patients
have some desire to present themselves as compliant[22].
The fact that no guardian/parents returned any left-over
drug, even if not all doses were taken according to the
electronic pill-box monitoring, may be compatible with
this desire to be compliant.
Electronic pillbox monitoring allows a more objective
and accurate monitoring of medication adherence, show-
ing clearly lower levels of adherence. Although electronic
pillbox monitoring is accepted to yield a fairly objective
quantitative estimate, independent from many variables
that could bias the estimates and may be less intrusive
than direct observation, this method is not free from lim-
itations either. The boxes can be opened without medica-
tion being taken, thus causing an overestimation of the
medication adherence. Medication adherence may also
be underestimated by electronic pill-box monitoring.
This happens when multiple doses are taken out at one
pill-box opening[9,23]. Therefore, it should be advised to
combine electronic pillbox monitoring with interrogation
on accidental opening and taking multiple doses at 1 pill-
box opening. In the Rwandan setting, where parents/
guardians use to spend the all journey in the field-mainly
in subsistence agriculture, one could assume that the pill-
Table 1: Medication adherence according to different adherence definitions, assessed by electronic pill-box monitoring.
Adherence definition Inpatient*
(10 doses)
Outpatient*
(11 doses)
Whole 
treatment*
(21 doses)#
(A) > 70% doses taken 54/54 (100.0%) 45/54 (83.3%) 45/54 (83.3%)
(B) > 80% doses taken 54/54 (100.0%) 42/54(77.8%) 42/54(77.8%)
(C) > 90% doses taken 52/54 (96.3%) 25/54 (46.3%) 23/54 (42.6%)
(D) > 80% of doses within four hours around due time (delayed/advanced of 
two hours)
53/54 (98.1%) 38/54 (70.4%) 32/54 (59.3%)
(E) > 80% of doses within two hours around due time (delayed/advanced of one 
hour)
39/54(72.2%) 22/54(40.7%) 18/54(33.3%)
*number of patients (and percentage) adherent according to adherence definition
# Overall adherence can be lower than the minimum of in- and outpatient adherence when the non-adherent children in the inpatient setting 
are different from those in the outpatient setting.
Figure 1 Recorded clock time of opening of the electronically 
monitored pill-boxes. The figure 1 shows the percentage of total 
openings recorded with electronically monitored pill-boxes by clock 
time.Twagirumukiza et al. Malaria Journal 2010, 9:206
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box was not always carried with them and multiple doses
were taken out at home as a provision. However, when
inspecting the dispersion of box-openings in time in the
outpatient setting, boxes were not opened more often in
the morning than they were in the afternoon or in the
evening. If patients wish to deceive the method, they
must open the electronically monitored pillbox on the
same time as if they should actually take the pills[11,24].
Although electronic pillbox monitoring may be a refer-
ence tool of medication adherence evaluation, its high
cost should be emphasized. This may limit their use to
specific studies such as the evaluation of interventions
intended to improve treatment adherence.
Furthermore, some parents/guardians reported that
their child vomited and that the dose was replaced within
30 minutes. This means the child should have received
more than the prescribed number of eleven doses. Since
each parent/guardian received eleven doses upon dis-
charge from the hospital and not one parent/guardian
came back to the hospital for refill, this causes an incon-
sistency in the medication adherence assessment that
could not be solved via either adherence monitoring
method.
The variability in adherence is mainly driven by the
variability in the ambulatory setting since at the hospital
the adherence was nearly 100%. This high hospital adher-
ence resulted in an effective decrease in parasitaemia and
appropriate quinine plasma levels at discharge from the
hospital[17] and may explain why despite the altered con-
sumers' adherence no treatment failure has been reported
in the present study.
Conclusion
Electronic pillbox monitoring proves superior to pill
count and patient self-report in medication adherence
assessment, which suggests that also in short treatment
interventions in the sub-Saharan setting it could be used
as a reference tool for treatment adherence assessment.
The present study also shows a markedly lower adher-
ence in the outpatient setting (consumers' adherence)
than in the inpatient setting (health workers' adherence).
This lower medication adherence applies to not only the
number of doses, but also to the right timing of dosing. In
outpatients, the evening doses were the most adhered,
followed by the morning doses.
Table 2: Number of missed doses, as measured by electronic pill-box monitoring.
Settings Total number of missed 
doses
range of missed doses per 
patient
Medication adherence expressed as % of doses 
taken (95% CI)
Inpatient
10 doses per patient
2 doses 0 to 2 doses 99.3 (96.6-100.0)
Outpatient
11 doses per patient
72 doses 0 to 6 doses 82.7 (68.0-97.4)
In total 74 doses 0 to 6 doses 90.5 (82.2-98.8)
Table 3: Doses taken in time: comparison between hospitalized versus outpatient setting, as measured by electronic pill-
box monitoring.
The time when the dose has been taken, compared with 
the prescribed time.
hospitalisation period (429 doses) outpatient period (568 doses) p-value
Number of doses % Number of doses %
doses taken too late more than 1 hour 40 9.3 89 15.7 0.013*
more than 2 hours 2 0.5 23 4.0 0.002*
doses taken too early more than 1 hour 11 2.6 49 8.6 0.001*
more than 2 hours 5 1.2 26 4.6 0.003*
*Statistically significant between hospitalization and the outpatient periodTwagirumukiza et al. Malaria Journal 2010, 9:206
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The present study also shows that an appropriate in
hospital treatment period may decrease treatment failure
and probably also drug resistance.
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